Does diabetes impact therapeutic immunomodulation therapy decisions for kidney transplant recipients? Data from the Folic Acid for Vascular Outcome Reduction in Transplant (FAVORIT) trial

Larry Weinrauch, John D'Elia, Matthew Weir, Suphamai Bunnapradist, Peter Finn, Jiankang Liu, Brian Claggett, Anthony Monaco
  • International Journal of Nephrology and Renovascular Disease, August 2017, Dove Medical Press
  • DOI: 10.2147/ijnrd.s139901

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

open access logoRead Publication

http://dx.doi.org/10.2147/ijnrd.s139901

The following have contributed to this page: Larry Weinrauch

In partnership with: